Objective: In order to assess the long-term (12 months) efficacy and safety of fenofibrate administered with simvastatin in the treatment of primary mixed hyperlipidaemia, we conducted a study that ...

1. Should all patients with apparent hyperlipidaemia have further blood tests to rule out an underlying cause such as diabetes or hypothyroidism? Yes, it is generally recommended that patients with ...

Peters, J. P., and Van Slyke, D. D., Quantitative Clinical Chemistry; Methods, 321 (Williams and Wilkins Co., Baltimore, 1932). Handbook of Respiration, edit. by ...

The use of simvastatin combined with fibrates is generally thought to be potentially hazardous, unless the benefit of further improvement in lipid and lipoprotein levels in patients at high ...